Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Amy Franks

Concepts (188)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Education, Pharmacy
16
2024
142
8.260
Why?
Schools, Pharmacy
7
2023
53
3.490
Why?
Pharmacy
3
2023
58
2.130
Why?
Professional-Patient Relations
3
2019
47
1.300
Why?
Teaching
4
2024
117
1.120
Why?
Educational Measurement
6
2019
210
1.030
Why?
Faculty
5
2024
66
1.020
Why?
Writing
3
2022
37
0.910
Why?
Students, Pharmacy
4
2021
121
0.910
Why?
Students
3
2024
210
0.900
Why?
Pharmaceutical Services
2
2023
55
0.880
Why?
Fellowships and Scholarships
2
2020
111
0.840
Why?
Learning
2
2024
158
0.840
Why?
Pharmacies
1
2023
61
0.810
Why?
Humans
40
2024
49827
0.730
Why?
Patient-Centered Care
2
2019
128
0.710
Why?
Motivational Interviewing
2
2019
32
0.700
Why?
Health Knowledge, Attitudes, Practice
4
2018
488
0.670
Why?
Program Development
2
2018
166
0.610
Why?
Blood Pressure
3
2012
514
0.610
Why?
Probucol
2
2009
3
0.610
Why?
Patient Education as Topic
2
2011
295
0.600
Why?
Achievement
1
2017
39
0.590
Why?
Mass Screening
2
2011
351
0.580
Why?
Perception
1
2017
116
0.560
Why?
Cross-Sectional Studies
7
2020
1541
0.540
Why?
Feedback
1
2016
53
0.530
Why?
Tetrazoles
2
2008
41
0.530
Why?
Antihypertensive Agents
2
2009
115
0.520
Why?
Hypertension
3
2009
532
0.500
Why?
Health Personnel
1
2017
241
0.490
Why?
Curriculum
5
2019
404
0.420
Why?
Community Health Services
2
2011
101
0.410
Why?
Energy Drinks
1
2012
6
0.410
Why?
Caffeine
1
2012
67
0.390
Why?
Platelet Aggregation Inhibitors
2
2012
174
0.390
Why?
Faculty, Medical
2
2023
90
0.380
Why?
Coronary Disease
1
2011
132
0.370
Why?
Cardiovascular Diseases
3
2012
440
0.360
Why?
Female
16
2024
26329
0.350
Why?
Adrenergic beta-Antagonists
1
2009
102
0.330
Why?
Cardiovascular System
1
2009
49
0.330
Why?
Biphenyl Compounds
1
2008
30
0.320
Why?
Angiotensin II Type 1 Receptor Blockers
1
2008
44
0.310
Why?
Benzimidazoles
1
2008
48
0.310
Why?
Male
14
2024
25093
0.300
Why?
Thiazolidinediones
1
2007
82
0.280
Why?
Coronary Restenosis
1
2005
31
0.260
Why?
Hypoglycemic Agents
1
2007
166
0.260
Why?
Clinical Trials as Topic
4
2009
460
0.240
Why?
Smoking
2
2018
510
0.230
Why?
Career Mobility
1
2023
25
0.230
Why?
Policy
1
2023
24
0.230
Why?
Organizational Policy
1
2023
40
0.220
Why?
Academies and Institutes
1
2023
18
0.220
Why?
Communication
2
2022
244
0.220
Why?
Checklist
1
2023
28
0.220
Why?
Angiotensin Receptor Antagonists
1
2003
19
0.220
Why?
Research Personnel
1
2023
62
0.210
Why?
Imidazoles
1
2003
119
0.200
Why?
Schools
1
2023
165
0.200
Why?
Angiotensin II
1
2003
157
0.200
Why?
Heart Failure
1
2007
454
0.200
Why?
Adult
10
2023
13160
0.200
Why?
Diabetes Mellitus, Type 2
1
2007
467
0.190
Why?
Itraconazole
3
2008
40
0.190
Why?
Qualitative Research
1
2023
325
0.190
Why?
Amiodarone
1
2000
22
0.190
Why?
Cannabis
1
2023
145
0.180
Why?
Anti-Arrhythmia Agents
1
2000
79
0.180
Why?
Blood Pressure Monitoring, Ambulatory
2
2012
36
0.180
Why?
Mentors
1
2020
55
0.180
Why?
Heart Arrest
2
2007
148
0.180
Why?
Self Report
1
2020
192
0.160
Why?
Peer Review
1
2018
9
0.160
Why?
Self-Assessment
2
2016
46
0.150
Why?
Pilot Projects
3
2009
699
0.150
Why?
Publishing
1
2018
39
0.150
Why?
Motivation
1
2020
273
0.150
Why?
Risk Factors
4
2011
3619
0.150
Why?
Knowledge
1
2017
28
0.150
Why?
Universities
1
2017
156
0.140
Why?
Citrus paradisi
2
2008
10
0.140
Why?
Food-Drug Interactions
2
2008
14
0.140
Why?
Education, Pharmacy, Graduate
1
2016
19
0.140
Why?
Tobacco Products
1
2018
110
0.130
Why?
Pharmacists
3
2023
144
0.130
Why?
Arkansas
3
2023
1967
0.120
Why?
Middle Aged
7
2023
11997
0.120
Why?
Young Adult
3
2018
3936
0.120
Why?
Retrospective Studies
2
2024
6117
0.110
Why?
Antifungal Agents
2
2008
339
0.110
Why?
United States
2
2021
4838
0.110
Why?
Dose-Response Relationship, Drug
2
2008
1374
0.100
Why?
Ticlopidine
1
2012
55
0.100
Why?
Proton Pump Inhibitors
1
2012
84
0.100
Why?
Life Style
1
2011
140
0.090
Why?
Drug Interactions
3
2012
206
0.090
Why?
Atenolol
1
2009
13
0.090
Why?
Cerebrovascular Disorders
1
2009
54
0.090
Why?
Health Behavior
1
2011
251
0.090
Why?
Drug Tolerance
1
2009
60
0.080
Why?
Drug Evaluation, Preclinical
1
2009
144
0.080
Why?
Problem-Based Learning
1
2008
43
0.080
Why?
Beverages
2
2008
68
0.080
Why?
Hirudins
1
2007
16
0.070
Why?
Education, Medical, Undergraduate
1
2008
82
0.070
Why?
Anaphylaxis
1
2007
71
0.070
Why?
Edema
1
2007
67
0.070
Why?
Drugs, Investigational
1
2005
14
0.070
Why?
Students, Medical
1
2008
159
0.070
Why?
Weight Gain
1
2007
240
0.060
Why?
Insulin Resistance
1
2007
264
0.060
Why?
Molecular Structure
1
2005
297
0.060
Why?
Insulin
1
2007
457
0.060
Why?
Risk Assessment
1
2009
1262
0.060
Why?
beta-Cyclodextrins
1
2004
16
0.060
Why?
Anticoagulants
1
2007
254
0.060
Why?
Tachycardia, Ventricular
2
2003
43
0.060
Why?
Antioxidants
1
2005
248
0.060
Why?
Ephedra
1
2003
8
0.060
Why?
Electrocardiography, Ambulatory
1
2003
23
0.060
Why?
Phytotherapy
1
2003
44
0.060
Why?
Plant Preparations
1
2003
37
0.060
Why?
Receptors, Angiotensin
1
2003
13
0.050
Why?
Prescription Fees
1
2003
14
0.050
Why?
Hemostasis
1
2003
55
0.050
Why?
Adolescent
2
2018
6340
0.050
Why?
Practice Guidelines as Topic
2
2007
448
0.050
Why?
Animals
2
2009
13150
0.050
Why?
Aged, 80 and over
1
2009
3125
0.050
Why?
Hepatocytes
1
2003
181
0.050
Why?
Interleukin-6
1
2003
264
0.050
Why?
Ventricular Fibrillation
1
2000
16
0.050
Why?
Attitude of Health Personnel
1
2023
348
0.040
Why?
Aged
2
2012
9272
0.040
Why?
Dietary Supplements
1
2003
441
0.040
Why?
Attitude
1
2019
69
0.040
Why?
Cardiopulmonary Resuscitation
1
2000
133
0.040
Why?
Liver
1
2003
1109
0.040
Why?
Risk
1
2018
320
0.040
Why?
Pregnant Women
1
2018
77
0.040
Why?
Nicotine
1
2018
186
0.040
Why?
Societies, Pharmaceutical
1
2016
12
0.030
Why?
Attitude to Health
1
2018
191
0.030
Why?
Pharmaceutical Solutions
2
2008
8
0.030
Why?
Pandemics
1
2021
554
0.030
Why?
Child
1
2008
6824
0.030
Why?
Accreditation
1
2016
61
0.030
Why?
Area Under Curve
2
2008
181
0.030
Why?
Cross-Over Studies
2
2008
224
0.030
Why?
Time Factors
2
2012
2912
0.030
Why?
Regression Analysis
1
2012
395
0.020
Why?
Acute Coronary Syndrome
1
2012
78
0.020
Why?
Proportional Hazards Models
1
2012
406
0.020
Why?
Pregnancy
1
2018
2584
0.020
Why?
Cohort Studies
1
2012
1422
0.020
Why?
Peer Group
1
2008
54
0.020
Why?
Hospitalization
1
2012
653
0.020
Why?
Cytochrome P-450 CYP3A
1
2008
78
0.020
Why?
Risk Management
1
2007
32
0.020
Why?
Injections, Intravenous
1
2007
140
0.020
Why?
Follow-Up Studies
1
2012
2179
0.020
Why?
Antibodies
1
2007
155
0.020
Why?
Administration, Oral
1
2008
423
0.020
Why?
Program Evaluation
1
2008
349
0.020
Why?
Renal Insufficiency
1
2007
109
0.020
Why?
Respiratory Insufficiency
1
2007
112
0.020
Why?
Recombinant Proteins
1
2007
486
0.020
Why?
Sex Factors
1
2008
693
0.020
Why?
Clinical Competence
1
2008
398
0.020
Why?
Cyclodextrins
1
2004
17
0.010
Why?
Biological Availability
1
2004
121
0.010
Why?
Ephedrine
1
2003
21
0.010
Why?
Cimetidine
1
2003
7
0.010
Why?
Receptors, Interleukin-6
1
2003
22
0.010
Why?
Diastole
1
2003
69
0.010
Why?
Bradycardia
1
2003
36
0.010
Why?
Systole
1
2003
68
0.010
Why?
Reference Values
1
2003
310
0.010
Why?
Cytochrome P-450 Enzyme System
1
2003
195
0.010
Why?
Patient Compliance
1
2003
230
0.010
Why?
Heart Rate
1
2003
292
0.010
Why?
Body Weight
1
2003
513
0.010
Why?
Enzyme Inhibitors
1
2003
391
0.010
Why?
Body Mass Index
1
2003
652
0.010
Why?
Cells, Cultured
1
2003
1571
0.010
Why?
Treatment Outcome
1
2003
5138
0.010
Why?
Franks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description